Personalized mRNA Therapy Shows Positive Phase 3 Results in Melanoma
Merck and Moderna report positive Phase 3 results for their personalized mRNA…
$80.5 Million Public Offering to Fund Development of Investigational Cancer Treatment
An $80.5 million public offering will support clinical trials, manufacturing and development…
VANFLYTA® Commercialization Agreement Expands Access to AML Treatment in China
Innovent Biologics and Daiichi Sankyo enter an exclusive agreement to commercialize VANFLYTA®…
Lacutamab Advances Toward Phase 3 Trial in T-Cell Lymphoma
Sobi and Innate Pharma partner to advance lacutamab into a Phase 3…
FDA Grants Breakthrough Therapy Designation to Olomorasib for Advanced Pancreatic Cancer
The U.S. FDA has granted Breakthrough Therapy designation to Lilly's investigational KRAS…
WHO Marks 25 Years of Research4Life Expanding Global Access to Scientific Knowledge
WHO is celebrating 25 years of Research4Life, a global partnership that has…
Strategic Research Partnership Expands Patient Access to Clinical Trials
A new strategic research partnership aims to expand patient access to clinical…
Major Acquisition to Advance Therapies for Treatment-Resistant Depression
Lilly will acquire AtaiBeckley in a deal valued at up to $3.8…
EU Approves First Oral GLP-1 Treatment for Weight Management
The European Commission has approved Wegovy® pill as the EU's first oral…
Novo Nordisk Collaborates with Vivani Medical to Evaluate Long-Acting Semaglutide Implant
A new collaboration will evaluate a long-acting semaglutide implant for chronic weight…
